Results from a number of scientific studies suggest that berries rich in anthocyanins — particularly black raspberries – may have potential in the prevention and supportive treatment of certain cancers, including blood cancers, according to EastFruit.
What the research shows
Studies conducted by scientists at The Ohio State University examined the bioactive compounds found in black raspberries (Rubus occidentalis). Data published in scientific journals, including Cancer Research and the Journal of Agricultural and Food Chemistry, indicate that anthocyanins and cyanidin derivatives may induce apoptosis (programmed cell death) in tumor cells in laboratory models.
In several in vitro experiments, researchers observed inhibition of leukemia cell proliferation after treatment with extracts rich in cyanidin-3-rutinoside. Importantly, the impact on healthy cells was significantly less pronounced, which is a critical factor from a toxicity perspective.
Mechanism of action
Anthocyanins are natural polyphenolic compounds responsible for the red, purple, and dark blue color of many berries. According to researchers, these compounds may:
-
reduce oxidative stress;
-
influence signaling pathways associated with tumor growth;
-
activate apoptosis mechanisms;
-
modulate inflammatory processes.
Similar bioactive compounds are also found in blueberries, blackberries, and grapes.
Despite promising laboratory results, scientists emphasize that most findings so far come from preclinical studies. Large-scale clinical trials that would allow berries to be considered an independent treatment for blood cancers are currently lacking.
Oncohematological diseases, including leukemia, are currently treated using chemotherapy, targeted therapy, immunotherapy, and bone marrow transplantation. Dietary factors may play a supportive role, but they cannot replace established medical treatment protocols.
The scientific community continues to study natural polyphenols as a potential basis for developing less toxic anticancer drugs.
Experts stress that regular consumption of anthocyanin-rich berries can be part of a healthy diet; however, any decisions regarding cancer treatment must be made exclusively under medical supervision.
Thus, the discussion is not about a “miracle cure,” but rather about a scientifically grounded research direction that may complement modern oncology therapies in the future.
The use of the site materials is free if there is a direct and open for search engines hyperlink to a specific publication of the East-Fruit.com website.
